- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 30
Veza eases out of stealth
GV was among the investors that provided over $110m for data authorisation software startup Veza as it emerged from stealth.
May 3, 2022Daily Deal Round Up: April 29, 2022
Content personalisation technology provider Movable Ink and carbon-negative concrete developer Brimstone each raised $55m, with Intel and Amazon respectively among the investors.
Apr 29, 2022Corporates sign up to 10-figure Securonix round
Capital One Ventures, Snowflake Ventures, Verizon Ventures and Wipro Ventures were all named as participants in a round for the cloud security software provider sized above $1bn.
Apr 29, 2022OneFootball marks off $300m series D round
Animoca Brands and Dapper Labs were among the investors in the football media provider’s latest round, which came alongside the launch of its blockchain-driven fan engagement platform OneFootball Labs.
Apr 29, 2022Freewire plugs into $125m
BP Ventures was among the participants in a round reportedly valuing the EV charging network and technology developer at $525m.
Apr 29, 2022Ford finds $130m road to Cavnue
Intelligent road technology developer Cavnue raised the cash in a series A round co-led by Ford Motor Company while two other strategic partners, Globalvia and Landstar, also invested.
Apr 29, 2022Qualified crosses i's on $95m series C
Salesforce Ventures, an investor in the sales generation software developer since seed stage, returned for a round hiking its overall funding to $158m.
Apr 29, 2022Daily Deal Round Up: April 28, 2022
Call centre software producer Replicant closed a $78m series B round backed by Salesforce Ventures while Ashvattha Therapeutics raised $69m from investors including strategic partner Huadong Medicine.
Apr 28, 2022Ruqi mobilises $153m in series A round
GAC has returned to lead the Tencent and Guangzhou Public Transport-backed automated taxi developer’s latest round, which included WeRide and Pony.ai.
Apr 28, 2022RVAC Medicines arms itself with funding
GS Group contributed to a series B round that pushed messenger RNA therapeutics and vaccine developer RVAC Medicines' overall funding to $140m.
Apr 28, 2022About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


